CNBX Pharmaceuticals Inc. (CNBX) Return on Sales (2016 - 2024)
CNBX Pharmaceuticals' (CNBX) quarterly Return on Sales came in at 0.11% in Q4 2024, down 9.0% YoY from 0.13% in Q4 2023, and down 144.38% on a QoQ basis from 0.05% in Q3 2024.
CNBX Pharmaceuticals Inc. (CNBX) Return on Sales (2016 - 2024) Analysis & Trends
CNBX Pharmaceuticals (CNBX) has 9 years of Return on Sales data on file, last reported at 0.11% in Q4 2024.
- Quarterly Return on Sales fell 9.0% year-over-year to 0.11% in Q4 2024, while the trailing twelve-month figure through Nov 2024 was 0.11% (down 10.0% YoY) and the FY2024 annual result came in at 0.31%, down 21.0% from the prior year.
- Return on Sales declined to 0.11% in Q4 2024, from 0.05% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.01% in Q2 2023 to a low of 31.72% in Q2 2021.
- A 5-year average of 5.69% and a median of 0.38% in 2023 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2021 — Return on Sales slumped 2806 bps — and 2023, when it jumped 90 bps.
- Tracing CNBX's Return on Sales over 5 years: stood at 12.04% in 2020, then slumped by 164 bps to 31.72% in 2021, then surged by 97 bps to 0.92% in 2022, then surged by 98 bps to 0.02% in 2023, then plunged by 456 bps to 0.11% in 2024.
- The last three Return on Sales figures came in at 0.11% (Q4 2024), 0.05% (Q3 2024), and 0.03% (Q2 2024), per Business Quant data.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2024 | -0.11% |
| Aug 31, 2024 | -0.05% |
| May 31, 2024 | -0.03% |
| Feb 29, 2024 | -0.05% |
| Nov 30, 2023 | -0.02% |
| Aug 31, 2023 | -0.02% |
| May 31, 2023 | -0.01% |
| Feb 28, 2023 | -0.59% |
| Nov 30, 2022 | -0.92% |
| Aug 31, 2022 | -0.16% |
| May 31, 2021 | -31.72% |
| Feb 28, 2021 | -15.56% |
| Nov 30, 2020 | -12.04% |
| Aug 31, 2020 | -19.42% |
| May 31, 2020 | -3.66% |
| Feb 29, 2020 | -6.61% |
| Nov 30, 2019 | -4.65% |
| Aug 31, 2019 | -14.45% |
| May 31, 2019 | -3.61% |
| Feb 28, 2019 | -3.86% |